TFO Wealth Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
TFO Wealth Partners's GILD Position: Q2 2024 in Review
TFO Wealth Partners sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 15 shares — an estimated $1.1K sold.
TFO Wealth Partners first reported a position in GILD in Q4 2019 and held it in 14 quarters. The position peaked at $37K in Q1 2020. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.
- TFO Wealth Partners reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
- TFO Wealth Partners sold 15 Gilead Sciences shares in Q2 2024, an estimated $1.1K.
- TFO Wealth Partners first reported a position in Gilead Sciences in Q4 2019 and held it in 14 quarters.
- TFO Wealth Partners's Gilead Sciences position peaked at $37K in Q1 2020.
- 1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.
Based on TFO Wealth Partners's 13F filing for Q2 2024, filed 15 Aug 2024.